Ana səhifə

Section I: Surgical Biology Chapter 1: Inflammatory Response references

Yüklə 3.38 Mb.
ölçüsü3.38 Mb.
1   ...   10   11   12   13   14   15   16   17   ...   55

Chapter 25: Introduction to Oncologic Surgery for the General Surgeon


  1. Alberico RA, Husain SH, Sirotkin I: Imaging in head and neck oncology. Surg Oncol Clin North Am 13:13, 2004. PUBMED Abstract

  2. Aper RL, Smeak DD: Clinical evaluation of caudal superficial epigastric axial pattern flap reconstruction of skin defects in 10 dogs (1989–2001). J Am Anim Hosp Assoc 41:185, 2005. PUBMED Abstract

  3. Aper RL, Smeak DD: Complications and outcome after thoracodorsal axial pattern flap reconstruction of forelimb skin defects in 10 dogs, 1989–2001. Vet Surg 32:378, 2003. PUBMED Abstract

  4. Argyle DJ, Khanna C: Tumor biology and metastasis. In Withrow SJ, Vail DM, editors: Withrow & MacEwen’s small animal clinical oncology, ed 4, St Louis, 2007, Saunders, p 31.

  5. Ashton JA, Farese JP, Milner RJ, et al: Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs. Am J Vet Res 66:885, 2005. PUBMED Abstract

  6. Avril NE, Weber WA: Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 43:189, 2005. PUBMED Abstract

  7. Bacon NJ, Dernell WS, Ehrhart N, et al: Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999–2004). J Am Vet Med Assoc 230:548, 2007. PUBMED Abstract

  8. Bacon NJ, Dernell WS, Ehrhart N, et al: Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999–2004). J Am Vet Med Assoc 230:548, 2007. PUBMED Abstract

  9. Banks T, Straw R, Thomson M, Powers B: Soft tissue sarcomas in dogs: a study assessing surgical margin, tumour grade and clinical outcome. Aust Vet J 34:158, 2004.

  10. Batsakis JG: Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol 6:140, 1999. PUBMED Abstract

  11. Ben-Eliyahu S: The price of anticancer intervention: does surgery promote metastasis? Lancet Oncol 3:578, 2002. PUBMED Abstract

  12. Berg J, Gebhardt MC, Rand WM: Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 79:1343, 1997. PUBMED Abstract

  13. Berg J, Lamb CR, O’Callaghan MW: Bone scintigraphy in the initial evaluation of dogs with primary bone tumors. J Am Vet Med Assoc 196:917, 1990. PUBMED Abstract

  14. Berg J: Surgical therapy. In Slatter D, editor: Textbook of small animal surgery, ed 3, Philadelphia, 2003, Saunders, p 2324.

  15. Bergman PJ, Camps-Palau MA, McKnight JA, et al: Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24:4582, 2006. PUBMED Abstract

  16. Bergman PJ, McKnight J, Novosad A, et al: Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Clin Cancer Res 9:1284, 2003. PUBMED Abstract

  17. Bergman PJ: Anticancer vaccines. Vet Clin North Am Small Anim Pract 37:1111, 2007. PUBMED Abstract

  18. Bernstein JA, Hodgin EC, Holloway HW, et al: Mohs micrographic surgery: a technique for total margin assessment in veterinary cutaneous oncologic surgery. Vet Comp Oncol 4:151, 2006. PUBMED Abstract

  19. Biller BJ, Dow S: Immunotherapy of cancer. In Withrow SJ, Vail DM, editors: Withrow & MacEwen’s small animal clinical oncology, ed 4, St Louis, 2007, Saunders, p 212.

  20. Blasdale C, Charlton FG, Weatherhead SC, et al: Effect of tissue shrinkage on histological tumour-free margin after excision of basal cell carcinoma. Br J Dermatol 162:607, 2009. PUBMED Abstract

  21. Bostock DE, Dye MT: Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 17:581, 1980. PUBMED Abstract

  22. Boudrieau RJ, McCarthy RJ, Sisson RD, Jr: Sarcoma of the proximal portion of the tibia in a dog 5.5 years after tibial plateau leveling osteotomy. J Am Vet Med Assoc 227:1613, 2005. PUBMED Abstract

  23. Byers RM, Bland KI, Borlase B, et al: The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 136:525, 1978. PUBMED Abstract

  24. Campo MS: Cell transformation by animal papillomaviruses. J Gen Virol 73:217, 1992. PUBMED Abstract

  25. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 407:249, 2007.

  26. Carr I, Pettigew N, Weinerman B: Lymphatic metastasis and its treatment. Cancer Treat Rev 14:53, 1987. PUBMED Abstract

  27. Chabner B, Longo DL: Cancer chemotherapy and biotherapy: principles and practice, Philadelphia, 2006, Lippincott Williams & Wilkins.

  28. Chen TY, Emrich LJ, Driscoll DL: The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Radiat Oncol Biol Phys 13:833, 1987. PUBMED Abstract

  29. Choo R, Woo T, Assaad D, et al: What is the microscopic tumor extent beyond clinically delineated gross tumor boundary in nonmelanoma skin cancers? Int J Radiat Oncol Biol Phys 62:1096, 2005. PUBMED Abstract

  30. Chun R, Garrett LD, Vail DM: Cancer chemotherapy. In Withrow SJ, MacEwen EG, editors: Small animal clinical oncology, ed 3, Philadelphia, 2007, Saunders.

  31. Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339, 2006. PUBMED Abstract

  32. Clifford CA, Pretorius ES, Weisse C, et al: Magnetic resonance imaging of focal splenic and hepatic lesions in the dog. J Vet Intern Med 18:330, 2004. PUBMED Abstract

  33. Cole S, Tannock I: Drug resistance. In Tannock I, Hill R, editors: The basic science of oncology, New York, 2005, McGraw-Hill.

  34. Coley W: The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med 3:1, 1910. PUBMED Abstract

  35. Cox C, Centeno B, Dickson D, et al: Accuracy of intraoperative imprint cytology for sentinel lymph node evaluation in the treatment of breast carcinoma: a 6-year study. Cancer 105:13, 2005. PUBMED Abstract

  36. Da Costa ML, Redmond P, Bouchier-Hayes DJ: The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 124:516, 1998. PUBMED Abstract

  37. Dahl K, Westlin J, Kraaz W, et al: Identification of sentinel nodes in patients with colon cancer. Eur J Surg Oncol 31:381, 2005. PUBMED Abstract

  38. Daly MK, Saba CF, Crochik SS, et al: Fibrosarcoma adjacent to the site of microchip implantation in a cat. J Feline Med Surg 10:202, 2008. PUBMED Abstract

  39. Darnell JE, Jr: Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740, 2002. PUBMED Abstract

  40. Dennis R: Imaging features of orbital myxosarcomas in dogs. Vet Radiol Ultrasound 49:256, 2008. PUBMED Abstract

  41. DeRegis CJ, Moore AS, Rand WM, Berg J: Cisplatin and doxorubicin toxicosis in dogs with osteosarcoma. J Vet Intern Med 17:668, 2003. PUBMED Abstract

  42. Dernell WS, Straw RC, Withrow SJ: Tumors of the skeletal system. In Withrow SJ, MacEwen EG, editors: Small animal clinical oncology, ed 3, Philadelphia, 2001, Saunders, p 378.

  43. Dernell WS, Withrow SJ, Kuntz CA, Powers BE: Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13:59, 1998. PUBMED Abstract

  44. Dernell WS, Withrow SJ: Preoperative patient planning and margin evaluation. Clin Tech Small Anim Pract 13:17, 1998. PUBMED Abstract

  45. Dernell WS, Withrow SJ: Preoperative patient planning and margin evaluation. Clin Tech Small Anim Pract 13:17, 1998. PUBMED Abstract

  46. DeVita VT, Hellman S, Rosenberg SA: Cancer: principles & practice of oncology, Philadelphia, 1997, Lippincott-Raven.

  47. DiNardo LJ, Lin J, Karageorge LS, et al: Accuracy, utility, and cost of frozen section margins in head and neck cancer surgery. Laryngoscope 110:1773, 2000. PUBMED Abstract

  48. Downing S, Chien MB, Kass PH, et al: Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit in mast cell tumors of dogs. Am J Vet Res 63:1718, 2002. PUBMED Abstract

  49. Dunning D: Surgical wound infection and the use of antimicrobials. In Slatter D, editor: Textbook of small animal surgery, ed 3, Philadelphia, 2003, Saunders, p 113.

  50. Einstein R, Sorgente N, Soble LW, et al: The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73:765, 1973. PUBMED Abstract

  51. Ellis JA, Jackson ML, Bartsch RC, et al: Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats. J Am Vet Med Assoc 209:767, 1996. PUBMED Abstract

  52. Elmslie RE, Glawe P, Don SW: Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 22:1373, 2008. PUBMED Abstract

  53. Emmenegger U, Man S, Shaked Y: A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens. Cancer Res 64:3994, 2004. PUBMED Abstract

  54. Estourgie SH, Nieweg OE, Kroon BBR: The sentinel node procedure in patients with melanoma. Eur J Surg Oncol 30:713, 2004. PUBMED Abstract

  55. Ettinger SN: Principles of treatment for soft-tissue sarcomas in the dog. Clin Tech Small Anim Pract 18:118, 2003. PUBMED Abstract

  56. Fan TM, Charney SC, de Lorimier LP, et al: Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. J Vet Intern Med 23:152, 2009. PUBMED Abstract

  57. Fan TM, de Lorimier LP, Garrett LD, Lacoste HI: The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. J Vet Intern Med 22:380, 2008. PUBMED Abstract

  58. Fan TM, de Lorimier LP, O’Dell-Anderson K, et al: Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. J Vet Intern Med 21:431, 2007. PUBMED Abstract

  59. Fan TM: The role of bisphosphonates in the management of patients that have cancer. Vet Clin North Am Small Anim Pract 37:1091, 2007. PUBMED Abstract

  60. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759, 1990. PUBMED Abstract

  61. Fidler IJ: Regulation of neoplastic angiogenesis. J Natl Cancer Inst Monogr 28:10, 2001. PUBMED Abstract

  62. Fisher B, Fisher E: Barrier function of the lymph node to tumor cells and erythrocytes. I. Normal nodes. Cancer 20:1907, 1967. PUBMED Abstract

  63. Fisher B, Fisher E: Barrier function of the lymph node to tumor cells and erythrocytes. II: Effect of x-ray, inflammation, sensitization and tumor growth. Cancer 20:1914, 1967. PUBMED Abstract

  64. Forrest LJ, Chun R, Adams WM, et al: Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 14:578, 2000. PUBMED Abstract

  65. Fortner JG: Inadvertent spread of cancer at surgery. J Surg Oncol 53:191, 1993. PUBMED Abstract

  66. Fry RJ, Ley RD: Ultraviolet radiation carcinogenesis. In Slaga TJ, editor: Mechanisms of tumor promotion, vol II, Boca Raton, FL, 1983, CRC Press, p 73.

  67. Fulcher R, Ludwig L, Bergman P, et al: Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 228:210, 2006. PUBMED Abstract

  68. García-Olmo DC, Gutiérrez-González L, Samos J, et al: Surgery and hematogenous dissemination: comparison between the detection of circulating tumor cells and of tumor DNA in plasma before and after tumor resection in rats. Ann Surg Oncol 13:1136, 2006. PUBMED Abstract

  69. Garden OA, Reubi JC, Dykes NK, et al: Somatostatin receptor imaging in vivo by planar scintigraphy facilitates the diagnosis of canine insulinomas. Vet Radiol Ultrasound 19:168, 2005. PUBMED Abstract

  70. Gibbs CP, Peabody TD, Mundt AJ, et al: Oncologic outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities. J Bone Joint Surg Am 79-A:888, 1997. PUBMED Abstract

  71. Gilson SD, Stone EA: Principles of oncologic surgery. Compend Contin Educ Pract Vet 12:827, 1990.

  72. Gilson SD: Clinical management of the regional lymph node. In Gilson SD, editor: Surgical oncology, Philadelphia, 1995, WB Saunders, p 149.

  73. Gilson SD: Clinical management of the regional lymph node. In Gilson SD, editor: Surgical oncology, Philadelphia, 1995, WB Saunders, p 149.

  74. Gius JA: Fundamentals of general surgery, ed 2, Chicago, 1962, Year Book Medical Publishers.

  75. Glickman LT, Domanski LM, Maguire TG, et al: Mesothelioma in pet dogs associated with exposure of their owners to asbestos. Environ Res 32:305, 1983. PUBMED Abstract

  76. Graham JC, O’Keefe DA: Diagnosis and treatment of soft tissue sarcomas. Compendium 15:1627, 1993.

  77. Grosslinger K, Alton K, Lorinson D: Histological examination of tumour margins and evaluation of recurrence rate in feline vaccine-associated fibrosarcoma. Kleintierpraxis 48:261, 2003.

  78. Hakem R, Harrington L: Cell death. In Tannock I, Hill R, et al, editors: Oncogenes and tumor suppressor genes in the basic science of oncology, New York, 2005, McGraw-Hill Medical Publishing, p 194.

  79. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57, 2000. PUBMED Abstract

  80. Harbison ML, Godleski JJ: Malignant mesothelioma in urban dogs. Vet Pathol 20:531, 1983. PUBMED Abstract

  81. Hargis AM, Ihrke PJ, Spangler WL, Stannard AA: A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29:316, 1992. PUBMED Abstract

  82. Hart I, Saina A: Biology of metastasis. The Lancet 339:1453, 1992. PUBMED Abstract

  83. Hart IR: Seed and soil revisited: mechanisms of site-specific metastasis. Cancer Met Rev 1:5, 1982.

  84. Henry C: Chemical, physical, and hormonal factors. In Withrow SJ, Vail DM, editors: Withrow & MacEwen’s small animal clinical oncology, ed 4, St Louis, Saunders, 2007, p 12.

  85. Henry CJ, Stoll MR, Higginbotham ML, et al: Effect of timing of radiation initiation on post-surgical wound healing in dogs. Proc Vet Cancer Soc 23:52, 2003.

  86. Hershey AE, Sorenmo KU, Hendrick MJ, et al: Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216:58, 2000. PUBMED Abstract

  87. Hosoya K, Kisseberth WC, Alvarez FJ, et al: Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors. J Am Anim Hosp Assoc 45:14, 2009. PUBMED Abstract

  88. Jankowski MK, Steyn PF, Lana SE, et al: Nuclear scanning with 99mTc-HDP for the initial evaluation of osseous metastasis in canine osteosarcoma. Vet Comp Oncol 1:152, 2003. PUBMED Abstract

  89. Jerusalem G, Hustinx R, Beguin Y, et al: The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Ann Oncol 13(suppl 4):227, 2002. PUBMED Abstract

  90. Jeys JM, Grimer RJ, Carter SR, et al: Post operative infection and increased survival in osteosarcoma patients: are they associated? Ann Surg Oncol 14:2887, 2007. PUBMED Abstract

  91. Johnson RE, Sigman JD, Funk GF, et al: Quantification of surgical margin shrinkage in the oral cavity. Head Neck 19:281, 1997. PUBMED Abstract

  92. Jónasdóttir TJ, Mellersh CS, Moe L, et al: Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci U S A 97:4132, 2000. PUBMED Abstract

  93. Karakousis CP: Principles of surgical dissection. J Surg Oncol 21:205, 1982. PUBMED Abstract

  94. Kawaguchi N, Matumoto S, Manabe J: New method of evaluating the surgical margin and safety margin for musculoskeletal sarcoma, analysed on the basis of 457 surgical cases. J Cancer Res Clin Oncol 121:555, 1995. PUBMED Abstract

  95. Kerwin SC, Mauldin GE: Hemostasis, surgical bleeding, and transfusion. In Slatter D, editor: Textbook of small animal surgery, ed 3, Philadelphia, 2003, Saunders, p 44.

  96. Khanna C, Anderson PM, Hasz DE, et al: Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer 79:1409, 1997. PUBMED Abstract

  97. Kharti VP, Goodnight JE: Extremity soft tissue sarcoma: controversial management issues. Surg Oncol 14:1, 2005. PUBMED Abstract

  98. Kirpensteijn J, Kik M, Teske E, Rutteman GR: TP53 gene mutations in canine osteosarcoma. Vet Surg 37:454, 2008. PUBMED Abstract

  99. Kitagawa Y, Fujii H, Kumai K, et al: Recent advances in sentinel lymph node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol 90:147, 2005. PUBMED Abstract

  100. Knight K, Wade S, Balducci L: Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(suppl 7A):11S, 2004. PUBMED Abstract

  101. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820, 1971.

  102. Kolb BA, Buller RE, Connor JP, et al: Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 79:988, 1992. PUBMED Abstract

  103. Kow K, Thamm DH, Terry J, et al: Impact of telomerase status on canine osteosarcoma patients. J Vet Intern Med 22:1366, 2008. PUBMED Abstract

  104. Kumar V, Robbins SL: Neoplasia. In Robbins basic pathology, ed 8, Philadelphia, 2007, Saunders, p 107.

  105. Kuntz CA, Dernell WS, Powers BE, et al: Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986–1996). J Am Vet Med Assoc 211:1147, 1997. PUBMED Abstract

  106. Kuntz CA: Sarcoma surgery technique debated. Vet Pract News 13:5, 2001.

  107. Kyles AE, Feldman EC, De Cock HEV, et al: Surgical management of adrenal gland tumors with and without associated tumor thrombi in dogs: 40 cases (1994–2001). J Am Vet Med Assoc 223:654, 2003. PUBMED Abstract

  108. Lachowicz JL, Post GS, Brodsky E: A phase I clinical trial evaluating imatinib mesylate (Gleevec) in tumor-bearing cats. J Vet Intern Med 19:860, 2005. PUBMED Abstract

  109. Lana S, U’ren L, Plaza S, et al: Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. J Vet Intern Med 21:764, 2007. PUBMED Abstract

  110. Lascelles BD, Dernell WS, Correa MT, et al: Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol 12:1073, 2005. PUBMED Abstract

  111. LeCouteur RA: Current concepts in the diagnosis and treatment of brain tumours in dogs and cats. J Small Anim Pract 40:411, 1999. PUBMED Abstract

  112. Lee CH, Kim WH, Lim JH, et al: Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. J Vet Sci 5:63, 2004. PUBMED Abstract

  113. Leibman NF, Kuntz CA, Steyn PF, et al: Accuracy of radiography, nuclear scintigraphy, and histopathology for determining the proximal extent of distal radial osteosarcoma in dogs. Vet Surg 30:240, 2001. PUBMED Abstract

  114. Liao AT, Chien MB, Shenoy N, et al: Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100:585, 2002. PUBMED Abstract

  115. Liao AT, McCleese J, Kamerling S, et al. A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma. Vet Comp Oncol 5:177, 2007. PUBMED Abstract

  116. Liao JC, Gregor P, Wolchock JD, et al: Vaccination with human tyrosinase DNA induces antibody responses in dogs with advanced melanoma. Cancer Immun 6:8, 2006. PUBMED Abstract

  117. Liu S, Moore M: Pharmacology of anticancer drugs. In Tannock I, Hill R, editors: The basic science of oncology, New York, 2005, McGraw-Hill Medical Publications.

  118. London CA, Hannah AL, Zadovoskaya R, et al: Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 9:2755, 2003. PUBMED Abstract

  119. London CA, Malpas PB, Wood-Follis SL, et al: Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clin Cancer Res 15:3856, 2009. PUBMED Abstract

  120. London CA: The role of small molecule inhibitors for veterinary patients. Vet Clin North Am Small Anim Pract 37:1121, 2007. PUBMED Abstract

  121. Looser KG, Shah JP, Strong EW: The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg 1:107, 1978. PUBMED Abstract

  122. Loree TR, Strong EW: Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 160:410, 1990. PUBMED Abstract

  123. Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491, 1989. PUBMED Abstract

  124. MacEwen EG, Kutzke J, Carew J, et al: c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells. Clin Exp Metastasis 20:421, 2003. PUBMED Abstract

  125. MacEwen EG: Hemangiosarcoma. In Withrow SJ, MacEwen EG, editors: Small animal clinical oncology, ed 3, Philadelphia, 2001, Saunders, p 639.

  126. Mankoff DA, Dehdashi F, Shields AF: Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia 2:71, 2000. PUBMED Abstract

  127. Mann FA, Pace LW: Marking margins of tumorectomies and excisional biopsies to facilitate histological assessment of excision completeness. Semin Vet Med Surg (Small Anim) 8:279, 1993. PUBMED Abstract

  128. Manoso MW, Frassica DH, Deune EG, et al: Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas. J Surg Oncol 91:153, 2005. PUBMED Abstract

  129. Markowitz SD, Bertagnolli MM: Molecular basis of colorectal cancer. N Engl J Med 361:2449, 2009. PUBMED Abstract

  130. Marks SL: The principles and practical application of enteral nutrition. Vet Clin North Am Small Anim Pract 28:677, 1998. PUBMED Abstract

  131. McChesney SL, Withrow SJ, Gillette EL, et al: Radiotherapy of soft tissue sarcomas in dogs. J Am Vet Med Assoc 194:60, 1989. PUBMED Abstract

  132. McEntee MC, Samii VF, Walsh P, et al: Postoperative assessment of surgical clip position in 16 dogs with cancer: a pilot study. J Am Anim Hosp Assoc 40:300, 2004. PUBMED Abstract

  133. McEntee MC, Steffey M, Dykes NL: Use of hemoclips in radiation treatment planning. Vet Radiol Ultrasound 49:395, 2008. PUBMED Abstract

  134. McEntee MC: Principles of adjunct radiotherapy and chemotherapy. Vet Clin North Am Small Anim Pract 25:133, 1995. PUBMED Abstract

  135. McGuire DB: Occurrence of cancer pain. J Natl Cancer Inst Monogr 32:51, 2004. PUBMED Abstract

  136. McKnight JA, Mauldin GN, McEntee MC, et al: Radiation treatment of incompletely resected soft-tissue sarcomas in dogs. J Am Vet Med Assoc 217:205, 2000. PUBMED Abstract

  137. Mealey KL, Fidel J, Gay JM, et al: ABCB1-1Delta polymorphism can predict hematologic toxicity in dogs treated with vincristine. J Vet Intern Med 22:996, 2008. PUBMED Abstract

  138. Mealey KL, Meurs KM: Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping. J Am Vet Med Assoc 233:921, 2008. PUBMED Abstract

  139. Mealey KL: Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 27:257, 2004. PUBMED Abstract

  140. Meléndez RD, Suárez-Pellín C: Spirocerca lupi and dogs: the role of nematodes in carcinogenesis. Trends Parasitol 17:516, 2001. PUBMED Abstract

  141. Michels GM, Knapp DW, DeNicola DB, et al: Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 38:458, 2002. PUBMED Abstract

  142. Milner RJ, Farese J, Henry CJ, et al: Bisphosphonates and cancer. J Vet Intern Med 18:597, 2004. PUBMED Abstract

  143. Modiano JF, Breen M, Burnett RC, et al: Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk. Cancer Res 65:5654, 2005. PUBMED Abstract

  144. Mohs FE: Chemosurgical treatment of cancer of the ear: a microscopically controlled method of excision. Surgery 21:605, 1947. PUBMED Abstract

  145. Mulligan G, Jacks T: The retinoblastoma gene family: cousins with overlapping interests. Trends Genet 14:223, 1998. PUBMED Abstract

  146. Murgia C, Pritchard JK, Kim SY, et al: Clonal origin and evolution of a transmissible cancer. Cell 126:477, 2006. PUBMED Abstract

  147. Nasir L, Devlin P, McKevitt T, et al: Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology. Neoplasia 3:351, 2001. PUBMED Abstract

  148. Nogueras JJ, Jagelman DG: Principles of surgical resection: influence of surgical technique on treatment outcome: colorectal cancer. Surg Clin North Am 73:103, 1993. PUBMED Abstract

  149. O’Brien RT, Iani M, Matheson J, et al: Contrast harmonic ultrasound of spontaneous liver nodules in 32 dogs. Vet Radiol Ultrasound 45:547, 2004. PUBMED Abstract

  150. Olovnikov AM: Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol 31:443, 1996. PUBMED Abstract

  151. Owen LN, editor: TNM classification of tumors in domestic animals, Geneva, 1980, World Health Organization.

  152. Ozaki K, Yamagami T, Nomura K, Narama I: Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor. J Vet Med Sci 69:1117, 2007. PUBMED Abstract

  153. Paoloni MC, Adams WM, Dubielzig RR, et al: Comparison of results of computed tomography and radiography with histopathologic findings in tracheobronchial lymph nodes in dogs with primary lung tumors: 14 cases (1999–2002). J Am Vet Med Assoc 228:1718, 2006. PUBMED Abstract

  154. Park CC, Mitsumori M, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668, 2000. PUBMED Abstract

  155. Pauli BU, Augustin-Voss HG, El-Sabban ME, et al: Organ-preference of metastasis. Cancer Metastasis Rev 9:175, 1990. PUBMED Abstract

  156. Penn LZ: Apoptosis modulators as cancer therapeutics. Curr Opin Investig Drugs 2:684, 2001. PUBMED Abstract

  157. Peremans K, Kersemans V, Liuti T, et al: Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent n two dogs with synovial cell sarcoma. Vet Radiol Ultrasound 48:471, 2007. PUBMED Abstract

  158. Phillips JC, Stephenson B, Hauck M, Dillberger J: Heritability and segregation analysis of osteosarcoma in the Scottish deerhound. Genomics 90:354, 2007. PUBMED Abstract

  159. Poirier VJ, Burgess KE, Adams WM, Vail DM: Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. J Vet Intern Med 18:536, 2004. PUBMED Abstract

  160. Poston GJ: Is there a surgical oncology? In Textbook of surgical oncology, London, UK, 2007, Informa Healthcare, p 1.

  161. Poteet BA: Veterinary nuclear medicine. In Ettinger SJ, Feldman EC, editors: Textbook of veterinary internal medicine, ed 6, Philadelphia, 2005, Saunders, p 354.

  162. Potter BK, Adams SC, Pitcher JD, et al: Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res 466:3093, 2008. PUBMED Abstract

  163. Rapini RP: Comparison of methods for checking surgical margins. J Am Acad Dermatol 23:288, 1990. PUBMED Abstract

  164. Rassnick KM, Moore AS, Williams LE, et al: Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13:601, 1999. PUBMED Abstract

  165. Rebbeck CA, Thomas R, Breen M, et al: Origins and evolution of a transmissible cancer. Evolution 63:2340, 2009. PUBMED Abstract

  166. Reimer SB, Seguin B, DeCock HE, et al: Evaluation of the effect of routine histologic processing on the size of skin samples obtained from dogs. Am J Vet Res 66:500, 2009.

  167. Reinbach D, McGregor JR, O’Dwyer PJ: Effect of suture material on tumour cell adherence at sites of colonic injury. Br J Surg 80:774, 1993. PUBMED Abstract

  168. Ribeiro U, Safatle-Ribeiro AV, Zilberstein B, et al: Does the intraoperative peritoneal lavage cytology add prognostic information in patients with potentially curative gastric resection. J Gastrointest Surg 10:170, 2006. PUBMED Abstract

  169. Rivera P, Mellin M, Biagi T, et al: Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Cancer Res 69:8770, 2009. PUBMED Abstract

  170. Rizzo LB, Ritchey JW, Higbee RG, et al: Histologic comparison of skin biopsy specimens collected by use of carbon dioxide or 810-nm diode lasers from dogs. J Am Vet Med Assoc 225:1562, 2004. PUBMED Abstract

  171. Rodin G, Mackay JA, Zimmermann C, et al: Clinician-patient communication: a systematic review. Support Care Cancer 17:627, 2009. PUBMED Abstract

  172. Séguin B, Besancon MF, McCallan JL, et al: Recurrence rate, clinical outcome, and cellular proliferation indices as prognostic indicators after incomplete surgical excision of cutaneous grade II mast cell tumors: 28 dogs (1994–2002). J Vet Intern Med 20:933, 2006. PUBMED Abstract

  173. Séguin B, McDonald DE, Kent MS, et al: Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Vet Surg 34:214, 2005. PUBMED Abstract

  174. Semenza GL: Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 60:591, 2008. PUBMED Abstract

  175. Shander A, Knight K, Thurer R, et al: Prevalence and outcome of anemia in surgery: a systematic review of the literature. Am J Med 116(suppl 7A):58S, 2004. PUBMED Abstract

  176. Shiromizu A, Suematsu T, Yamaguchi K, et al: Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery 128:799, 2000. PUBMED Abstract

  177. Shriner DL, McCoy DK, Goldberg DJ, Wagner RF: Mohs micrographic surgery. J Am Acad Dermatol 39:79, 1998. PUBMED Abstract

  178. Sigurdson ER: Lymph node dissection: is it diagnostic or therapeutic? Am Soc Clin Oncol 21:965, 2003. PUBMED Abstract

  179. Simmons R, Thevarajah S, Brennan MB, et al: Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol 10:242, 2003. PUBMED Abstract

  180. Simpson AM, Ludwig LL, Newman SJ, et al: Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 224:236, 2004. PUBMED Abstract

  181. Simpson AM, Ludwig LL, Newman SJ, et al: Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 224:236, 2004. PUBMED Abstract

  182. Skorupski KA, Rodriguez CO, Krick EL, et al: Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol 7:139, 2009. PUBMED Abstract

  183. Soderstrom MJ, Gilson SD: Principles of surgical oncology. Vet Clin North Am Small Anim Pract 25:97, 1995. PUBMED Abstract

  184. Sottnik JL, U’Ren LW, Thamm DH, et al: Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunol Immunother 59:367, 2010. PUBMED Abstract

  185. Stefanello D, Morello E, Roccabianca P, et al: Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996–2006). Vet Surg 37:461, 2008. PUBMED Abstract

  186. Sugiura H, Takahashi M, Katagiri H, et al: Additional wide resections of malignant soft tissue tumors. Clin Orthop 394:201, 2002. PUBMED Abstract

  187. Taghian A, Mohiuddin M, Jagsi R, et al: Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241:629, 2005. PUBMED Abstract

  188. Takashima A: UVB-dependent modulation of epidermal cytokine network: roles in UVB-induced depletion of Langerhans cells and dendritic epidermal T cells. J Dermatol 22:876, 1995. PUBMED Abstract

  189. Tannock I, Hill R: Oncogenes and tumor suppressor genes. In The basic science of oncology, New York, 2005, McGraw-Hill Medical Publishing, p 123.

  190. Tannock I, Hill R: The basic science of oncology, New York, 2005, McGraw-Hill Medical Publishing.

  191. Tanvetyanon T, Clark JI, Campbell SC, et al: Neoadjuvant therapy: an emerging concept in oncology. South Med J 98:338, 2005. PUBMED Abstract

  192. Teifke JP, Löhr CV, Shirasawa H: Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet Microbiol 60:119, 1998. PUBMED Abstract

  193. Thamm DH, Vail DM: Mast cell tumors. In Withrow SJ, MacEwen EG, editors: Small animal clinical oncology, ed 3, Philadelphia, 2001, Saunders, p 261.

  194. Thomson M: Alimentary tract, liver, and pancreas. In Slatter D, editor: Textbook of small animal surgery, ed 3, Philadelphia, 2003, Saunders, p 2368.

  195. Townsend DW, Beyer T: A combined PET/CT scanner: the path to true image fusion. Br J Radiol 75:824, 2002. PUBMED Abstract

  196. Turnbull RB, Kyle K, Watson FR, et al: Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 166:420, 1967. PUBMED Abstract

  197. Vail DM, MacEwen EG, Kurzman ID, et al: Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial. Clin Cancer Res 1:1165, 1995. PUBMED Abstract

  198. Vail DM, Rodabaugh HS, Conder GA, et al: Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients. Vet Comp Oncol 5:38, 2007. PUBMED Abstract

  199. Veterinary Co-operative Oncology Group (VCOG): Veterinary Co-operative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncol 2:195, 2004. PUBMED Abstract

  200. Vikram B, Strong EW, Shah JP, et al: Failure of the primary site following multimodality treatment in advance head and neck cancer. Head Neck Surg 6:720, 1984. PUBMED Abstract

  201. Virkus WW, Marshall D, Enneking WF, et al: The effect of contaminated surgical margins revisited. Clin Orthop Relat Res 397:89, 2002. PUBMED Abstract

  202. Vogelstein B, Kinzler KW: The genetic basis of human cancer, New York, 2002, McGraw-Hill Medical Publishing.

  203. VonHoldt BM, Ostrander EA: The singular history of a canine transmissible tumor. Cell 126:445, 2006. PUBMED Abstract

  204. Wakui S, Muto T, Yokoo K, et al: Prognostic status of p53 gene mutation in canine mammary carcinoma. Anticancer Res 21:611, 2001. PUBMED Abstract

  205. Waldron DR, Zimmerman-Pope N: Superficial skin wounds. In Slatter D, editor: Textbook of small animal surgery, ed 3, Philadelphia, 2003, Saunders, p 259.

  206. Wallack ST, Wisner ER, Werner JA, et al: Accuracy of magnetic resonance imaging for estimating intramedullary osteosarcoma extent in pre-operative planning of canine limb-salvage procedures. Vet Radiol Ultrasound 43:432, 2002. PUBMED Abstract

  207. Waters D: Tumor metastasis: current biologic concepts and their implications for control of residual disease. In Gilson SD, editor: Surgical oncology, veterinary clinics of North America small animal practice, Philadelphia, 1995, WB Saunders, p 231.

  208. Weisse C, Shofer FS, Sorenmo K: Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38:71, 2002. PUBMED Abstract

  209. Williams LE, Packer RA: Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987–2001). J Am Vet Med Assoc 222:1234, 2003. PUBMED Abstract

  210. Wilson H, Huelsmeyer M, Chun R, et al: Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J 175:69, 2008. PUBMED Abstract

  211. Withrow SJ: Surgical oncology. In Withrow SJ, MacEwen EG, editors: Small animal clinical oncology, ed 3, Philadelphia, 2001, Saunders, p 70.

  212. Wong CK, Lam YL, So YC, et al: Management of extremity soft tissue sarcoma after unplanned incomplete resection: experience of a regional musculoskeletal tumour center. Hong Kong Med J 10:117, 2004. PUBMED Abstract
1   ...   10   11   12   13   14   15   16   17   ...   55

Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur © 2016
rəhbərliyinə müraciət